["{\n\"step_by_step_thinking\": \"There is no mention of CMB305 (Actinomycin D) specifically being used against sarcomas. However, it is mentioned as part of the CAIA regimen, which includes cyclophosphamide, adriamycin, imidazole carboxamide (DTIC), and actinomycin D (CAIA), in combination with or without MER-BCG for patients with advanced sarcomas.\",\n\"answer_choice\": \"A\"\n}"]